1
Clinical Trials associated with Insulin aspart biosimilar(Zhuhai United Laboratories Holding Ltd.)采用葡萄糖钳夹技术在健康男性受试者中进行 联邦制药门冬胰岛素注射液的药代动力学(PK) 和药效动力学(PD)研究
[Translation] A pharmacokinetic (PK) and pharmacodynamic (PD) study of the insulin aspart injection of United Lab in healthy male subjects using glucose clamp technique
采用葡萄糖钳夹技术对联邦制药门冬胰岛素注射液药代动力学(PK)和药效动力学(PD)进行研究,并与进口上市的诺和锐?相比较,有效地指导门冬胰岛素注射液的临床应用。
[Translation] The glucose clamp technique was used to study the pharmacokinetics (PK) and pharmacodynamics (PD) of the insulin aspart injection produced by United Lab, and compared with the imported NovoRapid, to effectively guide the clinical application of insulin aspart injection.
100 Clinical Results associated with Insulin aspart biosimilar(Zhuhai United Laboratories Holding Ltd.)
100 Translational Medicine associated with Insulin aspart biosimilar(Zhuhai United Laboratories Holding Ltd.)
100 Patents (Medical) associated with Insulin aspart biosimilar(Zhuhai United Laboratories Holding Ltd.)
100 Deals associated with Insulin aspart biosimilar(Zhuhai United Laboratories Holding Ltd.)